Merck (MRK) Was a Market Leader, is Now a Laggard as Money Moves
March 5, 2023
Merck (MRK) was a solid stock in 2022. Now in 2023, the shares are lagging the stock market as growth stock are in favor.
Research Reports
Pharmaceutical Stock Merck (MRK) is a Shining Star in this Bear Market
December 29, 2022
Merck (MRK) is the perfect stock for a Bear Market. Investors know this, that’s why the drug stock is doing so well right now.
Merck (MRK) Sock is a Safe Selection During this Bear Market
September 1, 2022
Merck (MRK) is a nice safe stock to own during a rough bear Market. But investors need to understand the growth might be slow.
Drug Stock Merck (MRK) May Be What the Stock Doctor Ordered
July 8, 2022
Merck (MRK) stock has some appeal for stock portfolios that are sick of this Bear Market. I like the low P/E of 13 and 3% yield.
Earnings
MRK 2023 Q2
February 28, 2023
Merck (MRK) is expected to report qtrly profits (EPS) and revenues:
Profits Estimates: $1.30 vs. $2.14 = -39%
Rev Est: $13,731 vs. $15,901 = -14%